CLINICAL_TRIALS
trial_result
· 2024-10-09
Clinical Trial Update: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa [Phase 2]
Summary
A Phase 2 trial evaluating spesolimab for hidradenitis suppurativa has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2024-10-09